1953•Experimental Biology and MedicineRequires access

Relationship of Pyridoxine and its Derivatives to the Mechanism of Action of Isoniazid.

Irene U. Boone, Kent T. Woodward

Open publisher page 28 citations

Abstract

1. It was possible to inhibit growth of organisms other than Mycobacterium with isoniazid by controlling the amount of pyridoxine and its derivatives in the media. Lactobacillus plantarum and Saccharomyces carlsbergensis were inhibited in a synthetic medium by isoniazid concentrations of less than 102 M. This inhibition was competitively reversed by pyridoxine, pyridox-amine, and pyridoxal. In reversing isoniazid inhibition of Lactobacillus, pyridoxamine, and pyridoxal were from 1000 to 4000 times more effective, than pyridoxine. 2. Two strains of E. coli were inhibited with isoniazid with partial reversal with pyridoxine and derivatives. Larger amounts of the metabolite were required and the reversal was not as typically competitive. 3. No reversal of isoniazid inhibition could be obtained with vit. B6 or its derivatives in any of the Mycobacteria tested. If isoniazid acts as an antagonist of pyridoxine or its derivatives in the Mycobacteria, it is not a simple substrate competition or uptake phenomenon.

About this research paper

What this paper is about

1. It was possible to inhibit growth of organisms other than Mycobacterium with isoniazid by controlling the amount of pyridoxine and its derivatives in the media. Lactobacillus plantarum and Saccharomyces carlsbergensis were inhibited in a synthetic medium by isoniazid concentrations of less than 102 M. This inhibition was competitively reversed by pyridoxine, pyridox-amine, and pyridoxal. In reversing isoniazid inhibition of Lactobacillus, pyridoxamine, and pyridoxal were from 1000 to 4000 times more effective, than pyridoxine. 2. Two strains of E. coli were inhibited with isoniazid with partial reversal with pyridoxine and derivatives. Larger amounts of the metabolite were required and the reversal was not as typically competitive. 3. No reversal of isoniazid inhibition could be obtained with vit. B6 or its derivatives in any of the Mycobacteria tested. If isoniazid acts as an antagonist of pyridoxine or its derivatives in the Mycobacteria, it is not a simple substrate competition or uptake phenomenon.

Why it matters

OpenAlex reports 28 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

1. It was possible to inhibit growth of organisms other than Mycobacterium with isoniazid by controlling the amount of pyridoxine and its derivatives in the media. Lactobacillus plantarum and Saccharomyces carlsbergensis were inhibited in a synthetic medium by isoniazid concentrations of less than 102 M. This inhibition was competitively reversed by pyridoxine, pyridox-amine, and pyridoxal. In reversing isoniazid inhibition of Lactobacillus, pyridoxamine, and pyridoxal were from 1000 to 4000 times more effective, than pyridoxine. 2. Two strains of E. coli were inhibited with isoniazid with partial reversal with pyridoxine and derivatives. Larger amounts of the metabolite were required and the reversal was not as typically competitive. 3. No reversal of isoniazid inhibition could be obtained with vit. B6 or its derivatives in any of the Mycobacteria tested. If isoniazid acts as an antagonist of pyridoxine or its derivatives in the Mycobacteria, it is not a simple substrate competition or uptake phenomenon.

Key concepts: Isoniazid, Pyridoxine, Pyridoxal, Metabolite, Pyridoxamine, Chemistry, Biochemistry, Microbiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Relationship of Pyridoxine and its Derivatives to the Mechanism of Action of Isoniazid. — Research Paper | ScholarLens